CN1054991C - Inhalation for cough and asthma and its preparing method - Google Patents
Inhalation for cough and asthma and its preparing method Download PDFInfo
- Publication number
- CN1054991C CN1054991C CN96114017A CN96114017A CN1054991C CN 1054991 C CN1054991 C CN 1054991C CN 96114017 A CN96114017 A CN 96114017A CN 96114017 A CN96114017 A CN 96114017A CN 1054991 C CN1054991 C CN 1054991C
- Authority
- CN
- China
- Prior art keywords
- grams
- sulfate
- gram
- calcium carbonate
- potassium iodide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
The present invention discloses an external application medicine for treating cough and asthma diseases, which is characterized in that ephedra, almond, mint, perilla, balloonflower, loquat leaves, gypsum, light calcium carbonate, cobalt acetate, potassium iodide, copper sulfate, ferrous sulfate heptahydrate, zinc sulphate, manganese sulphate, etc. are respectively ground, mixed and prepared to form an inhalant. The present invention can be used for treating cough and asthma diseases caused by various reasons.
Description
The present invention relates to a kind of medicine for the treatment of cough with asthma, specifically is a kind of news agent that is used for the treatment of cough with asthma, belongs to field of traditional Chinese.
Cough illness is one of common frdquently encountered disease clinically, generally is the symptom performance of acute and chronic tracheitis, various types of asthmas, and pilosity is born in autumn in winter.This onste is touching, is difficult for radical cure, and when arrived cold season, sickness rate was higher.Bring great misery to patient.Therapeutic Method for the present doctor trained in Western medicine of cough illness is a symptomatic treatment, for example, takes antitussive, antiallergic, antasthmatic etc., and still, this class medicine should not be taken for a long time, otherwise can bring side effect, also can produce dependency sometimes.Motherland's traditional medicine also has many Therapeutic Method to cough illness, the MAXINGSHIGAN TANG of treatise on Febrile Diseases for example, " the Herba Ephedrae Fructus Pruni sheet on the Chinese pharmacopoeia etc., this class preparation for treating effect is slow, curative effect is undesirable, and route of administration takes method oral or injection, and real be inconvenience.
The present invention seeks in order to overcome above-mentioned shortcoming, utilize a kind of news agent for the treatment of cough illness of a kind of new prepared.
The technical scheme that realizes the object of the invention is:
Choosing medical material Herba Ephedrae, Semen Armeniacae Amarum, Herba Menthae, Folium Perillae, Radix Platycodonis, Folium Eriobotryae, Gypsum Fibrosum is main material, adding precipitated calcium carbonate, cobaltous acetate, potassium iodide, copper, ferrum, zinc, manganese, magnesium are adjuvant, through selection, dry in the sun, baking, cut-out, pulverizing, grind to form 50-100 order fine powder respectively, after sieving, make the news agent through the compatibility hybrid process.
The composition of medicine of the present invention is as follows by weight:
Herba Ephedrae 2.1-3.2%
Semen Armeniacae Amarum 2.1-3.2%
Herba Menthae 1.5-3.2%
Folium Perillae 2.4-3.5%
Radix Platycodonis 1.5-3.2%
Folium Eriobotryae 1.4-1.8%
Gypsum Fibrosum 3.3-4.0%
Precipitated calcium carbonate 54.7-67.5%
Cobaltous acetate 0.12-0.16%
Potassium iodide 0.003-0.005%
Copper sulfate 2.1-3.5%
Ferrous sulfate 4.2-6.3%
Zinc sulfate 4.5-6.6%
Manganese sulfate 0.5-1.0%
Magnesium sulfate 4.2-6.3%
Medicine processing method of the present invention is:
At first cobaltous acetate and potassium iodide, mineral pulverize separately are crossed 50-100 mesh sieve mixing, and then mix with precipitated calcium carbonate according to the order of sequence successively, obtain mixed powder, Herba Ephedrae, Semen Armeniacae Amarum, Herba Menthae, Radix Platycodonis, Folium Perillae, Folium Eriobotryae, Gypsum Fibrosum are carried out drying one by one, pulverize mixing in the preceding mixed powder of adding again, through ultraviolet disinfection, packing.
Medicine of the present invention is heard agent and is compared with modern medicine treatment cough with asthma medicine, its advantage is to need not oral or injection for curing, the route of administration uniqueness, each effective ingredient of medicine interacts, and forms new lipid biology, and is volatile, the method of taking respiratory tract to suck, curative effect of medication is improved, and the treatment total effective rate reaches more than 90%, and to respiratory tract disease such as rhinitis with spirit is tired, infantile anorexia is all effective in cure.
With medicine of the present invention in Heilungkiang and China's extremely frigid zones such as east, Inner Mongol carried out clinical observation, treatment chronic bronchitis 72 examples, the effective percentage of having eliminated subjective symptomss such as cough with asthma, abundant expectoration, sensation of oppression over the chest with shortness of breath is respectively 90.2%, 88.%, 87.5%; Eliminate or the minimizing rale, the effective percentage that improves the lung marking disturbance state is respectively 79.2%, 73.6%.The treatment total effective rate is 83.96%.
Through Guangzhou Sanatorium, P.L.A.'s 48 routine clinical observations, treat the effective percentage 89.4% of breathing with cough, abundant expectoration effective percentage 83.3%, sensation of oppression over the chest with shortness of breath effective percentage 90.5%.
Now examine treatment chronic bronchitis effective percentage 90% through No.1 Hospital Affiliated to Beijing Medical Univ. is clinical.
Embodiment 1
Herba Ephedrae 2.1 grams
Semen Armeniacae Amarum 2.1 grams
Herba Menthae 1.5 grams
Folium Perillae 2.4 grams
Radix Platycodonis 1.5 grams
Folium Eriobotryae 1.4 grams
Gypsum Fibrosum 3.3 grams
Precipitated calcium carbonate 54.7 grams
Cobaltous acetate 0.12 gram
Potassium iodide 0.003 gram
Copper sulfate 2.1 grams
Ferrous sulfate 4.2 grams
Zinc sulfate 4.5 grams
Manganese sulfate 0.5 gram
Magnesium sulfate 4.2 grams
Mineral pulverize separately such as cobaltous acetate and potassium iodide, copper sulfate, ferrous sulfate, zinc sulfate, manganese sulfate, magnesium sulfate are crossed 100 mesh sieve mixings, and then mix with precipitated calcium carbonate according to the order of sequence successively, obtain mixed powder, Herba Ephedrae, Semen Armeniacae Amarum, Herba Menthae, Radix Platycodonis, Folium Perillae, Folium Eriobotryae, Gypsum Fibrosum are carried out drying one by one, pulverize mixing in the preceding mixed powder of adding again, through ultraviolet disinfection, packing.
Embodiment 2
Herba Ephedrae 3.2 grams
Semen Armeniacae Amarum 3.2 grams
Herba Menthae 3.2 grams
Folium Perillae 3.5 grams
Radix Platycodonis 3.2 grams
Folium Eriobotryae 1.8 grams
Gypsum Fibrosum 4.0 grams
Precipitated calcium carbonate 67.5 grams
Cobaltous acetate 0.16 gram
Potassium iodide 0.005 gram
Copper sulfate 3.5 grams
Ferrous sulfate 6.3 grams
Zinc sulfate 6.6 grams
Manganese sulfate 1.0 grams
Magnesium sulfate 6.3 grams
Mineral pulverize separately such as cobaltous acetate and potassium iodide, copper sulfate, ferrous sulfate, zinc sulfate, manganese sulfate, magnesium sulfate are crossed 100 mesh sieve mixings, and then mix with precipitated calcium carbonate according to the order of sequence successively, obtain mixed powder, Herba Ephedrae, Semen Armeniacae Amarum, Herba Menthae, Radix Platycodonis, Folium Perillae, Folium Eriobotryae, Gypsum Fibrosum are carried out drying one by one, pulverize mixing in the preceding mixed powder of adding again, through ultraviolet disinfection, packing.
Embodiment 3
Herba Ephedrae 2.2 grams
Semen Armeniacae Amarum 2.7 grams
Herba Menthae 1.8 grams
Folium Perillae 2.8 grams
Radix Platycodonis 3.1 grams
Folium Eriobotryae 1.5 grams
Gypsum Fibrosum 3.6 grams
Precipitated calcium carbonate 67.6 grams
Cobaltous acetate 0.15 gram
Potassium iodide 0.004 gram
Copper sulfate 1 gram
Ferrous sulfate 4 grams
Zinc sulfate 4.6 grams
Manganese sulfate 0.4 gram
Magnesium sulfate 4 grams
Mineral pulverize separately such as cobaltous acetate and potassium iodide, copper sulfate, ferrous sulfate, zinc sulfate, manganese sulfate, magnesium sulfate are crossed 100 mesh sieve mixings, and then mix with precipitated calcium carbonate according to the order of sequence successively, obtain mixed powder, Herba Ephedrae, Semen Armeniacae Amarum, Herba Menthae, Radix Platycodonis, Folium Perillae, Folium Eriobotryae, Gypsum Fibrosum are carried out drying one by one, pulverize mixing in the preceding mixed powder of adding again, through ultraviolet disinfection, packing.
Claims (3)
1, a kind of external medicine preparation for the treatment of cough illness is characterized in that it contains:
Herba Ephedrae 2.1-3.2%
Semen Armeniacae Amarum 2.1-3.2%
Herba Menthae 1.5-3.2%
Folium Perillae 2.4-3.5%
Radix Platycodonis 1.5-3.2%
Folium Eriobotryae 1.4-1.8%
Gypsum Fibrosum 3.3-4.0%
Precipitated calcium carbonate 54.7-67.5%
Cobaltous acetate 0.12-0.16%
Potassium iodide 0.003-0.005%
Copper sulfate 2.1-3.5%
Ferrous sulfate 4.2-6.3%
Zinc sulfate 4.5-6.6%
Manganese sulfate 0.5-1.0%
Magnesium sulfate 4.2-6.3%
2, pharmaceutical preparation according to claim 1 is characterized in that it contains:
Herba Ephedrae 2.2 grams
Semen Armeniacae Amarum 2.7 grams
Herba Menthae 1.8 grams
Folium Perillae 2.8 grams
Radix Platycodonis 3.1 grams
Folium Eriobotryae 1.5 grams
Gypsum Fibrosum 3.6 grams
Precipitated calcium carbonate 67.6 grams
Cobaltous acetate 0.15 gram
Potassium iodide 0.004 gram
Copper sulfate 1 gram
Ferrous sulfate 4 grams
Zinc sulfate 4.6 grams
Manganese sulfate 0.4 gram
Magnesium sulfate 4 grams
3,, it is characterized in that this pharmaceutical preparation is a kind of news agent according to the pharmaceutical preparation of claim 1 or 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96114017A CN1054991C (en) | 1996-12-31 | 1996-12-31 | Inhalation for cough and asthma and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96114017A CN1054991C (en) | 1996-12-31 | 1996-12-31 | Inhalation for cough and asthma and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1186667A CN1186667A (en) | 1998-07-08 |
| CN1054991C true CN1054991C (en) | 2000-08-02 |
Family
ID=5121892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96114017A Expired - Fee Related CN1054991C (en) | 1996-12-31 | 1996-12-31 | Inhalation for cough and asthma and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1054991C (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1070111A (en) * | 1991-09-11 | 1993-03-24 | 蒋永彰 | The manufacture method of cough and asthma snuff |
-
1996
- 1996-12-31 CN CN96114017A patent/CN1054991C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1070111A (en) * | 1991-09-11 | 1993-03-24 | 蒋永彰 | The manufacture method of cough and asthma snuff |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1186667A (en) | 1998-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1876049A (en) | An externally applied powder for treating infant diarrhea | |
| CN104306793B (en) | A kind of Chinese medicine preparation for treating lobar pneumonia | |
| CN101049337A (en) | Medication for curing furuncle, sore, and carbuncle, and preparation method | |
| CN1054991C (en) | Inhalation for cough and asthma and its preparing method | |
| CN1583001A (en) | Infrared cough relieving paste | |
| CN1049586C (en) | Dressing medicine for treating hyperosteogeny and the prepn. method | |
| CN1229129C (en) | Adhibition ointment for relieving cough | |
| CN1163251C (en) | Weishukang for treating gastrosis | |
| CN1720936A (en) | Medicine for treating breadth gasp, cough, asthma and phelgm | |
| CN100335091C (en) | External-use powder medicine for treating rhinitis | |
| CN1186028C (en) | Antagesic Chinese medicine and its preparing process and usage | |
| CN1136894C (en) | Medicinal composition for treating tuberculosis and its preparing process | |
| CN1281257C (en) | Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis | |
| CN1943732A (en) | A medicinal composition for treatment of psoriasis | |
| CN1296034C (en) | Halitosis removing toothpaste | |
| CN1876075A (en) | A medicine for treating asthma, acute and chronic bronchitis and preparation method thereof | |
| CN1163120A (en) | Medicine for curing tooth-ache and its preparation | |
| CN1234398C (en) | Oral medicine santong powder for treating arteriosclerosis and its manufacturing method | |
| CN1253195C (en) | Anti-age capsule of traditional Chinese medicine and preparation method | |
| CN1088365C (en) | Medicine for curing infectious gastrosis and its preparing process | |
| CN1068523C (en) | Medicine for treating cancer and its preparing technology | |
| CN1235624C (en) | Medicine for treating cancer and preparing process thereof | |
| CN1050056C (en) | Medicine for treating osteoproliferation | |
| CN1593590A (en) | Medicine for treating pulmonary tuberculosis and its preparing process | |
| CN1147313C (en) | Orally applied medicine 'Gukangwang' for treating arthropathy and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |